We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLS icon
2126
Telos
TLS
$358M
$5.17M ﹤0.01%
+136,408
New +$4.81M
HTLD icon
2127
Heartland Express
HTLD
$956M
$5.15M ﹤0.01%
263,135
-252,258
-49% -$4.79M
NESR
2128
National Energy Services Reunited Corp
NESR
$2.93B
$5.12M ﹤0.01%
413,783
+319,364
+338% +$3.75M
ADT icon
2129
ADT
ADT
$5.58B
$5.11M ﹤0.01%
605,340
+17,670
+3% +$153K
SAFE
2130
DELISTED
Safehold Inc.
SAFE
$5.1M ﹤0.01%
72,697
+607
+0.8% +$45.8K
CHWY icon
2131
Chewy
CHWY
$9.63B
$5.08M ﹤0.01%
59,989
-5,726
-9% -$557K
IMDX
2132
Insight Molecular Diagnostics
IMDX
$156M
$5.08M ﹤0.01%
48,942
+36,795
+303% +$3.49M
ORBC
2133
DELISTED
ORBCOMM, Inc.
ORBC
$5.08M ﹤0.01%
665,620
+294,334
+79% +$2.32M
ACCD
2134
DELISTED
Accolade Inc
ACCD
$5.08M ﹤0.01%
111,912
+61,999
+124% +$2.98M
ZNTL icon
2135
Zentalis Pharmaceuticals
ZNTL
$302M
$5.07M ﹤0.01%
116,900
+10,908
+10% +$470K
SPHR icon
2136
Sphere Entertainment
SPHR
$5.73B
$5.07M ﹤0.01%
61,927
-1,837
-3% -$183K
HFWA icon
2137
Heritage Financial
HFWA
$1.21B
$5.06M ﹤0.01%
179,266
-3,540
-2% -$92.7K
AMK
2138
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$5.06M ﹤0.01%
216,897
-14,619
-6% -$354K
CRSR icon
2139
Corsair Gaming
CRSR
$1.55B
$5.05M ﹤0.01%
151,734
+90,060
+146% +$3.35M
NGM
2140
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.02M ﹤0.01%
172,676
+72,696
+73% +$2.04M
EFT
2141
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$4.99M ﹤0.01%
353,668
ZGNX
2142
DELISTED
Zogenix, Inc.
ZGNX
$4.98M ﹤0.01%
255,043
-1,753
-0.7% -$36K
CXW icon
2143
CoreCivic
CXW
$3.19B
$4.9M ﹤0.01%
541,570
-4,430
-0.8% -$34.1K
IPAR icon
2144
Interparfums
IPAR
$3.94B
$4.89M ﹤0.01%
68,978
-852
-1% -$57.8K
TRST
2145
Trustco Bank Corp NY
TRST
$938M
$4.89M ﹤0.01%
132,646
-2,409
-2% -$84.9K
LGF.B
2146
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$4.89M ﹤0.01%
378,946
-8,829
-2% -$116K
ONT
2147
Onterris Inc
ONT
$580M
$4.88M ﹤0.01%
97,346
+61,635
+173% +$2.6M
UPLD icon
2148
Upland Software
UPLD
$15.4M
$4.88M ﹤0.01%
10,331
-116
-1% -$56K
WNC icon
2149
Wabash National
WNC
$527M
$4.86M ﹤0.01%
258,674
-7,059
-3% -$125K
AVID
2150
DELISTED
Avid Technology Inc
AVID
$4.86M ﹤0.01%
230,325
+2,230
+1% +$43.6K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.